vTv Therapeutics Inc.
VTVT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $98,806 | $114,015 | $79,698 |
| - Cash | $98,504 | $25,922 | $31,059 | $36,746 |
| + Debt | $0 | $79 | $125 | $169 |
| Enterprise Value | – | $72,963 | $83,081 | $43,121 |
| Revenue | $0 | $0 | $0 | $17 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | -$5 |
| % Margin | – | – | – | -29.4% |
| EBITDA | -$10,338 | -$7,718 | -$6,494 | -$4,415 |
| % Margin | – | – | – | -25,970.6% |
| Net Income | -$8,698 | -$6,046 | -$5,092 | -$3,634 |
| % Margin | – | – | – | -21,376.5% |
| EPS Diluted | -1.08 | -0.92 | -0.77 | -0.63 |
| % Growth | -17.4% | -19.5% | -22.2% | – |
| Operating Cash Flow | -$5,222 | -$5,095 | -$5,687 | -$4,825 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$5,222 | -$5,095 | -$5,687 | -$4,825 |